[Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
D000109:Acetylcholine / Q000378:metabolism; D000410:Alanine Transaminase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D001798:Blood Proteins / Q000032:analysis; D050260:Carbohydrate Metabolism; D002802:Cholinesterases / Q000378:metabolism; D002908:Chronic Disease; D004977:Ethambutol / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000378:metabolism
D001798:Blood Proteins; D004977:Ethambutol; D000410:Alanine Transaminase; D002802:Cholinesterases; D000469:Alkaline Phosphatase; D000109:Acetylcholine; D012293:Rifampin
Osobennosti obmennykh narusheniĭ u bol'nykh khronicheskim destruktivnym tuberkulezom legkikh posle lecheniia rifampitsinom i etambutolom